title: Recurrence of active tuberculosis following resumption of anti-TNF-α therapy in a patient with Crohn's disease.
authors.affiliation: Infectious Diseases Unit, Hospital General Universitario de Elche, Elche, Spain; Clinical Medicine Department, Universidad Miguel Hernández, Elche, Spain.
authors.forename: Mar
authors.initials: M
authors.lastname: Masiá
authors.affiliation: Infectious Diseases Unit, Hospital General Universitario de Elche, Elche, Spain.
authors.forename: Maravillas
authors.initials: M
authors.lastname: Martínez
authors.affiliation: Gastroenterology and Hepatology Section, Hospital General Universitario de Elche, Elche, Spain.
authors.forename: Mariana Fe
authors.initials: MF
authors.lastname: García-Sepulcre
authors.affiliation: Gastroenterology and Hepatology Section, Hospital General Universitario de Elche, Elche, Spain.
authors.forename: Jesús
authors.initials: J
authors.lastname: Sáez
authors.affiliation: Infectious Diseases Unit, Hospital General Universitario de Elche, Elche, Spain; Clinical Medicine Department, Universidad Miguel Hernández, Elche, Spain.
authors.forename: Félix
authors.initials: F
authors.lastname: Gutiérrez
mesh_terms: D000068879:Adalimumab; D061067:Antibodies, Monoclonal, Humanized / Q000008:administration & dosage / Q000009:adverse effects*; D000995:Antitubercular Agents / Q000627:therapeutic use*; D003424:Crohn Disease / Q000175:diagnosis / Q000188:drug therapy* / Q000276:immunology; D004334:Drug Administration Schedule; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000009:adverse effects*; D055985:Latent Tuberculosis / Q000175:diagnosis / Q000188:drug therapy / Q000276:immunology / Q000382:microbiology*; D008297:Male; D009169:Mycobacterium tuberculosis / Q000187:drug effects / Q000276:immunology / Q000472:pathogenicity*; D009894:Opportunistic Infections / Q000175:diagnosis / Q000188:drug therapy / Q000276:immunology / Q000382:microbiology*; D012008:Recurrence; D012307:Risk Factors; D013997:Time Factors; D016896:Treatment Outcome; D014397:Tuberculosis, Pulmonary / Q000175:diagnosis / Q000188:drug therapy / Q000276:immunology / Q000382:microbiology*; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*; D055815:Young Adult
chemical_list: D061067:Antibodies, Monoclonal, Humanized; D000995:Antitubercular Agents; D007166:Immunosuppressive Agents; D014409:Tumor Necrosis Factor-alpha; D000068879:Adalimumab